Specimen Collection From Pregnant Women at Increased Risk for Fetal AneuploidyStatus: open
[654939-10] Collection of Whole Blood Specimens from Pregnant Women at Increased Risk for Fetal Chromosomal Abnormality for use in Development of a Noninvasive Prenatal Test in Detection of the Relative Quantity of Chromosomal Material in Circulating Cell-Free DNA Extracted From Maternal Plasma
Treatment for Fetal Aneuploidy / Down Syndrome
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21. IRB Number 14-221
SponsorsThis trial is sponsored by Sequenom, Inc..
Interested in Clinical Trial?
Providers Associated With This Trial
- Susan L. Baker, M.D.Maternal-Fetal PhysicianDirector of Maternal Fetal Medicine Division; Associate Professor of Obstetrics and Gynecology